Top Markets
Coin of the day
Dali Pharmaceuticalco.,Ltd Dali Pharmaceuticalco.,Ltd

Dali Pharmaceuticalco.,Ltd

603963
Kedudukan dalam Saham #27024
Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the... Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the research, development, manufacturing, and distribution of medicinal products. The company specializes in injectable medications, offering a diverse portfolio of both traditional Chinese and Western formulations. This includes 20 distinct drug varieties, with a total of 44 approved specifications. Key examples from their product line are Xingnaojing, Shenmai, Astragalus, Leucocin A, and Citicoline injections. Dali Pharmaceutical also maintains a substantial intellectual property collection, holding 31 patents comprised of 11 invention patents, 16 utility models, and 3 design patents. Established in 1996, the company operates from its headquarters located in Dali, China.
Harga Saham
$0.16240909
Disegerakkan terakhir: 2025-03-04
Modal Pasaran
$35.68M
Perubahan (1 hari)
0.27%
Perubahan (1 tahun)
0.00%
Negara
CN
Perdagangan Dali Pharmaceuticalco.,Ltd (603963)

Kategori

Nisbah P/B bagi Dali Pharmaceuticalco.,Ltd (603963)
Nisbah P/B pada August 2026 TTM: 0.69
Menurut laporan kewangan dan harga saham terkini Dali Pharmaceuticalco.,Ltd, nisbah P/B semasa (TTM) ialah 0.69. Pada akhir 2022, nisbah P/B syarikat ialah 7.15.
Sejarah nisbah P/B untuk Dali Pharmaceuticalco.,Ltd dari 2012 hingga 2026
Nisbah P/B pada akhir setiap tahun
Tahun Nisbah P/B Ubah
2026 (TTM) 0.69 -90.07%
2023 6.94 -3.00%
2022 7.15 54.26%
2021 4.64 27.40%
2020 3.64 -10.88%
2019 4.08 16.91%
2018 3.49 -22.46%
2017 4.51 -29.63%
2016 6.40 36.88%
2015 4.68 39.56%
2014 3.35 -4.78%
2013 3.52 -35.78%
2012 5.48 0.00%
Nisbah P/B untuk syarikat atau pesaing yang serupa